Clinical Trial

Topotecan and Melphalan for Retinoblastoma

Name: Topotecan and Melphalan for Retinoblastoma — clinical trial record (NCT04799002)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated March 16, 2021 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.

Trial Details

NCT Number	NCT04799002
Lead Sponsor	Sun Yat-sen University
Conditions	Retinoblastoma, Chemotherapy Effect
Enrollment	50 participants
Start Date	2021-03-11
Primary Completion	2024-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2021-03-16